<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010092295">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Wongsawat, J.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Puthanakit, T.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Kanjanavanit, S.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Hansudewechakul, R.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Ngampiyaskul, C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Kerr, S. J.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Ubolyam, S.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Suwanlerk, T.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Kosalaraksa, P.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Luesomboon, W.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Ngo-Giang-Huong, Nicole</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Chandara, M.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Saphonn, V.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Ruxrungtham, K.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Ananworanich, J.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Cd4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus-infected children</title>
        <secondary-title>Pediatric Infectious Disease Journal</secondary-title>
      </titles>
      <pages>966-968</pages>
      <keywords>
        <keyword>HIV</keyword>
        <keyword>CD4</keyword>
        <keyword>antiretroviral treatment</keyword>
        <keyword>ART initiation</keyword>
        <keyword>WHO</keyword>
        <keyword>children</keyword>
        <keyword>Asia</keyword>
      </keywords>
      <dates>
        <year>2010</year>
      </dates>
      <call-num>fdi:010092295</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Pediatric Infectious Disease Journal</full-title>
      </periodical>
      <isbn>0891-3668</isbn>
      <accession-num>ISI:000282069700014</accession-num>
      <number>10</number>
      <electronic-resource-num>10.1097/INF.0b013e3181e0554c</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010092295</url>
        </related-urls>
        <pdf-urls>
          <url>https://www.documentation.ird.fr/intranet/publi/2024-12/010092295.pdf</url>
        </pdf-urls>
      </urls>
      <volume>29</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>We evaluated the validity of CD4 count against CD4% criteria of 2008 World Health Organization guideline for initiating antiretroviral therapy using the data of 446 human immunodeficiency virus-infected Asian children aged 1 to 12 years who were screened to the Pediatric Randomized of Early versus Deferred Initiation in Cambodia and Thailand study. The overall sensitivity and specificity were 34% and 98%, respectively. Using the current CD4 count criteria would globally result in 66% missed opportunity to initiate treatment in a timely fashion. Raising CD4 count thresholds should be considered to increase its sensitivity and reduce missed opportunity.</abstract>
      <custom6>052 ; 050</custom6>
      <custom1>UR174</custom1>
      <custom7>Cambodge / Thaïlande</custom7>
    </record>
  </records>
</xml>
